399 related articles for article (PubMed ID: 28738907)
1. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis.
Uruha A; Allenbach Y; Charuel JL; Musset L; Aussy A; Boyer O; Mariampillai K; Landon-Cardinal O; Rasmussen C; Bolko L; Maisonobe T; Leonard-Louis S; Suzuki S; Nishino I; Stenzel W; Benveniste O
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):513-522. PubMed ID: 30267437
[TBL] [Abstract][Full Text] [Related]
3. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
4. [Expression of retinoic acid-I nducible gene I in the muscle tissues of idiopathic inflammatory myopathies].
Lü J; Dai T; Li L; Li W; Ji K; Yan C
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(23):1823-8. PubMed ID: 26712399
[TBL] [Abstract][Full Text] [Related]
5. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
6. Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I.
Zhang L; Xia Q; Li W; Liu Q; Zhang L; Tian X; Ye L; Wang G; Peng Q
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36854567
[TBL] [Abstract][Full Text] [Related]
7. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
8. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis.
Duchesne M; Leonard-Louis S; Landon-Cardinal O; Anquetil C; Mariampillai K; Monzani Q; Benveniste O; Allenbach Y
Brain Pathol; 2020 Sep; 30(5):867-876. PubMed ID: 32323412
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis.
De Luna N; Suárez-Calvet X; Lleixà C; Diaz-Manera J; Olivé M; Illa I; Gallardo E
Sci Rep; 2017 Aug; 7(1):8595. PubMed ID: 28819164
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
Honda M; Shimizu F; Sato R; Nakamori M
J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
[TBL] [Abstract][Full Text] [Related]
11. Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
Suárez-Calvet X; Gallardo E; Nogales-Gadea G; Querol L; Navas M; Díaz-Manera J; Rojas-Garcia R; Illa I
J Pathol; 2014 Jul; 233(3):258-68. PubMed ID: 24604766
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
14. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
[TBL] [Abstract][Full Text] [Related]
15. Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM).
Civatte M; Schleinitz N; Krammer P; Fernandez C; Guis S; Veit V; Pouget J; Harlé JR; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):546-52. PubMed ID: 14636161
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies.
Caetano AM; Borges IBP; da Silva LMB; Shinjo SK
Clin Rheumatol; 2022 Nov; 41(11):3411-3417. PubMed ID: 35821168
[TBL] [Abstract][Full Text] [Related]
18. Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis.
Li L; Dai T; Lv J; Ji K; Liu J; Zhang B; Yan C
J Neuroimmunol; 2015 Aug; 285():161-8. PubMed ID: 26198935
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory muscle disease - An update.
Baig S; Paik JJ
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
